{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:32:06Z","timestamp":1793385126767,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122329","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:14:17Z","timestamp":1785338057000},"page":"122329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy, acceptability, and related outcomes of pharmacological interventions for acute bipolar mania: a systematic review and dose-related network meta-analysis across different age groups"],"prefix":"10.1016","volume":"414","author":[{"given":"Michele","family":"Fornaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Manuel","family":"Daray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122329_bb0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cts.12407","article-title":"Endoxifen, a new treatment option for mania: a double-blind, active-controlled trial demonstrates the antimanic efficacy of endoxifen","volume":"9","author":"Ahmad","year":"2016","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jad.2026.122329_bb0010","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"Bmj"},{"key":"10.1016\/j.jad.2026.122329_bb0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bdi.12324","article-title":"Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Arabzadeh","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41380-018-0044-2","article-title":"Pharmacological treatment of adult bipolar disorder","volume":"24","author":"Baldessarini","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122329_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"Netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jad.2026.122329_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/eip.13335","article-title":"Prevalence and correlates of childhood-onset bipolar disorder among adolescents","volume":"17","author":"Barton","year":"2023","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.jad.2026.122329_bb0035","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jad.2010.06.030","article-title":"Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose-response study","volume":"136","author":"Berwaerts","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40345-014-0014-9","article-title":"Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study","volume":"2","author":"Bourin","year":"2014","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0045","first-page":"132","article-title":"Efficacy and safety of low-and high-dose cariprazine in patients with acute mania associated with bipolar I disorder: P73","volume":"15","author":"Calabrese","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/11589060-000000000-00000","article-title":"Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder","volume":"31","author":"Citrome","year":"2011","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jad.2026.122329_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-5618.2010.00798.x","article-title":"Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials","volume":"12","author":"Correll","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapsychiatry.2017.0624","article-title":"Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence","volume":"74","author":"Correll","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122329_bb0065","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.clinthera.2011.10.002","article-title":"Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial","volume":"33","author":"Cutler","year":"2011","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2026.122329_bb0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.chi.0000159151.75345.20","article-title":"A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder","volume":"44","author":"Delbello","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2026.122329_bb0075","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.euroneuro.2010.07.003","article-title":"A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)","volume":"20","author":"El Mallakh","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122329_bb0080","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaac.2015.09.007","article-title":"Asenapine for the acute treatment of pediatric manic or mixed episode of bipolar I disorder","volume":"54","author":"Findling","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2026.122329_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/cap.2021.0121","article-title":"Efficacy, safety, and tolerability of flexibly dosed ziprasidone in children and adolescents with mania in bipolar I disorder: a randomized placebo-controlled replication study","volume":"32","author":"Findling","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122329_bb0090","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/NDT.S100846","article-title":"Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review","author":"Fornaro","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2026.122329_bb0095","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jad.2020.07.109","article-title":"The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials","volume":"276","author":"Fornaro","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jad.2023.06.068","article-title":"Psychopharmacology of eating disorders: systematic review and meta-analysis of randomized controlled trials","volume":"338","author":"Fornaro","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.121798","article-title":"Efficacy and safety of pharmacological interventions for the maintenance of bipolar disorder: a systematic review and dose-related network meta-analysis across different age groups","volume":"407","author":"Fornaro","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.122160","article-title":"Efficacy, acceptability, and related outcomes of pharmacological interventions for acute bipolar depression: a systematic review and dose-related network meta-analysis across different age groups","volume":"412","author":"Fornaro","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jagp.2024.12.006","article-title":"Effect of cariprazine on outcomes in older-aged and younger-aged patients with bipolar I disorder: a post-hoc analysis","volume":"33","author":"Garel","year":"2025","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2026.122329_bb0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jad.2014.11.013","article-title":"Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I","volume":"174","author":"Grunze","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1399-5618.2009.00750.x","article-title":"Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study","volume":"11","author":"Haas","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jad.2024.01.067","article-title":"A systematic review and network meta-analysis on comparative efficacy, acceptability, and safety of treatments in acute bipolar mania in youths","volume":"349","author":"Hesapcioglu","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0135","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2026.122329_bb0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.jad.2026.122329_bb0145","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (Updated February 2022)","author":"Higgins","year":"2022"},{"key":"10.1016\/j.jad.2026.122329_bb0150","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41380-024-02705-3","article-title":"Comparative efficacy, safety, and tolerability of pharmacotherapies for acute mania in adults: a systematic review and network meta-analysis of randomized controlled trials","volume":"30","author":"Huang","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122329_bb0155","series-title":"Some Pharmaceutical Drugs","article-title":"Tamoxifen","author":"IARC","year":"1996"},{"key":"10.1016\/j.jad.2026.122329_bb0160","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic-adrenergic hypothesis of mania and depression","volume":"300","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.122329_bb0165","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1176\/appi.focus.20230009","article-title":"The CANMAT and ISBD guidelines for the treatment of bipolar disorder: summary and a 2023 update of evidence","volume":"21","author":"Keramatian","year":"2023","journal-title":"Focus"},{"key":"10.1016\/j.jad.2026.122329_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000501210","article-title":"Effect of rivastigmine (acetyl cholinesterase inhibitor) versus placebo on manic episodes in patients with bipolar disorders: results from a double blind, randomized, placebo-controlled clinical trial","volume":"78","author":"Keshavrzi","year":"2019","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2026.122329_bb0175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jad.2016.09.037","article-title":"Long-term safety and tolerability of asenapine: a double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder","volume":"207","author":"Ketter","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0180","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41380-021-01334-4","article-title":"Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials","volume":"27","author":"Kishi","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122329_bb0185","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1503\/cmaj.101715","article-title":"Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression","volume":"184","author":"Knol","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.jad.2026.122329_bb0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials","volume":"8","author":"Kushner","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2015.06.059","article-title":"Asenapine: efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder","volume":"190","author":"Landbloom","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0200","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2026.122329_bb0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bdi.13367","article-title":"The diagnosis of bipolar disorder in children and adolescents: past, present and future","volume":"25","author":"Malhi","year":"2023","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0210","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.122329_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2026.122329_bb0220","article-title":"Bipolar disorders: an update on critical aspects","volume":"48","author":"Oliva","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.jad.2026.122329_bb0225","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122329_bb0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0269881118822167","article-title":"Tamoxifen for bipolar disorder: systematic review and meta-analysis","volume":"33","author":"Palacios","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122329_bb0235","series-title":"Haloperidol","author":"Rahman","year":"2020"},{"key":"10.1016\/j.jad.2026.122329_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122329_bb0245","series-title":"WebPlotDigitizer","author":"Rohatgi","year":"2017"},{"key":"10.1016\/j.jad.2026.122329_bb0250","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.jad.2026.122329_bb0255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/YIC.0000000000000592","article-title":"Risperidone as an adjuvant treatment for obsessive-compulsive symptoms in patients with bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial","volume":"41","author":"Sahraian","year":"2026","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122329_bb0260","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.jad.2026.122329_bb0265","article-title":"Dose-response meta-analysis: application and practice using the R software","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.jad.2026.122329_bb0270","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1038\/s41598-021-84836-z","article-title":"A network meta-analysis of the dose\u2013response effects of lurasidone on acute schizophrenia","volume":"11","author":"Srisurapanont","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2026.122329_bb0275","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122329_bb0280","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122329_bb0285","series-title":"R: A Language and Environment for Statistical Computing","author":"Team, R.C","year":"2023"},{"key":"10.1016\/j.jad.2026.122329_bb0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-5618.2009.00710.x","article-title":"Antipsychotic agents in the treatment of bipolar mania","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0295","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ije\/dys222","article-title":"Evaluation of inconsistency in networks of interventions","volume":"42","author":"Veroniki","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jad.2026.122329_bb0300","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bdi.12202","article-title":"Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and\/or antipsychotic agents in manic patients with bipolar disorder","volume":"16","author":"Weiser","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122329_bb0310","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.122329_bb0315","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S2215-0366(25)00338-4","article-title":"Dose-dependent pharmacological mechanisms within the neuroscience-based nomenclature: a new concept to facilitate neuroscience-based prescribing","volume":"13","author":"Zemach","year":"2026","journal-title":"Lancet Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726011821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726011821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:50:58Z","timestamp":1793382658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726011821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S0165032726011821"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122329","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, acceptability, and related outcomes of pharmacological interventions for acute bipolar mania: a systematic review and dose-related network meta-analysis across different age groups","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122329"}}